Sulfamerazine-D4,a deuterium-labeled version of Sulfamerazine,acts as a sulfonamide antibacterial. It inhibits the bacterial synthesis of dihydrofolic acid by competing with para-aminobenzoic acid (PABA)for the binding site on dihydropteroate synthase.